Page 8 - Rapid Detection News Today : Breaking News, Live Updates & Top Stories | Vimarsana

National Pork Board Julian Montoya Lopez, Juan Sanhueza, Carles Vilalta, Cesar Corzo, University of Minnesota | May 11, 2021 Porcine coronaviruses have been present in the U.S. swine industry for several years (Stevenson et al., 2013). Transmissible gastroenteritis virus (TGEV), porcine epidemic diarrhea virus (PEDV) and porcine Deltacoronavirus (PDCoV) continue to be part of the list of differential diagnosis when facing a clinical case of gastrointestinal disease (Marthaler et al., 2014; Turlewicz-Podbielska & Pomorska-Mól, 2021; Xia et al., 2018; Zimmerman., 2019). Unf...

Photo supplied by Web Industries An operator at Web Industries in Massachusetts loads cassette magazines of test devices onto a Campbell Revolution Flow Wrapper. Using a form-fill-seal approach, the equipment packs each test kit, together with a desiccant pack, in a metallized pouch. With help from a nimble partner, medical device giant BD took its rapid COVID-19 test kit from concept to large-scale production in a matter of months. For many in medical packaging, 2020 was a year of pandemic pivots that forced changes to packaging lines and tested the agility of medic...

Share this article Share this article FRANKLIN LAKES, N.J., April 23, 2021 /PRNewswire/ -- USA Track & Field (USATF) and BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, have partnered to provide rapid COVID-19 testing for USATF athletes at Journey to Gold meets to help get USATF professional athletes back to competition safely through the use of the BD Veritor™ Plus system. USA Track & Field (USATF) and BD have partnered to provide rapid COVID-19 testing for USATF athletes at Journey to Gold meets to help get USATF professional athletes back to ...

Share this article Share this article FRANKLIN LAKES, N.J., April 1, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its rapid antigen test to be used for SARS-CoV-2 screening through serial testing of asymptomatic individuals. BD today announced the FDA has granted Emergency Use Authorization (EUA) for its BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2 to be used for SARS-CoV-2 screening through serial t...

Share this article Share this article SILVER SPRING, Md., March 31, 2021 /PRNewswire/ -- Following recent U.S. Food and Drug Administration actions to support test development, the FDA took swift action this week to get more tests for screening asymptomatic individuals on the market. Today, the agency authorized several tests for over-the-counter (OTC) use without a prescription when used for serial screening. In addition to the tests authorized for OTC use, one serial screening test was authorized for use in a point-of-care (POC) setting without a prescription, and an additional screening te...